Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.98 is 61% below its 5-year average of 5.03, near the low end of its 5-year range (1.69–34.53).
As of the fiscal period ended Tuesday, June 30, 2026. 5.01% above its 12-month average of 1.88.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.98.
CURRENT RATIO
1.98
CURRENT RATIO AVG TTM
1.88
CURRENT RATIO AVG 3Y
2.02
CURRENT RATIO AVG 5Y
5.03
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.01%
CURRENT VS 3Y AVG
-2.29%
CURRENT VS 5Y AVG
-60.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-47.44%
vs the sector median at left
Market Cap
$78.07M
Current Ratio
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
Market Cap
$77.54M
Current Ratio
0.14
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$79.61M
Current Ratio
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $78.29M | 1.98 | 1.88 | 2.02 | 5.03 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | 1.00 | 2.08 | 2.75 | 4.86 |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | 12.48 | 10.44 | 6.35 | 4.73 |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | 0.73 | 0.45 | 0.43 | 0.43 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | 0.14 | 0.07 | 0.07 | 0.07 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 7.99 | 9.12 | 12.06 | 14.25 |
| Outset Medical, Inc. (OM)vs › | $76.74M | 5.19 | 6.18 | 6.20 | 7.03 |
| Humacyte, Inc. (HUMA)vs › | $80.30M | 6.21 | 3.04 | 4.62 | 7.16 |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | 1.76 | 4.33 | 6.41 | 6.77 |
| Nutriband Inc. (NTRB)vs › | $81.20M | 4.21 | 5.62 | 3.96 | 3.83 |
Current Ratio
1.98
Quick Ratio
1.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.98 |
| 2026-03-31 | 2.12 |
| 2025-12-31 | 1.69 |
| 2025-09-30 | 1.89 |
| 2025-06-30 | 1.73 |
| 2025-03-31 | 2.02 |
| 2024-12-31 | 1.92 |
| 2024-09-30 | 2.11 |
| 2024-06-30 | 2.08 |
| 2024-03-31 | 2.19 |
| 2023-12-31 | 2.51 |
| 2023-09-30 | 3.51 |
| 2023-06-30 | 4.54 |
| 2023-03-31 | 5.23 |
| 2022-12-31 | 5.80 |
| 2022-09-30 | 10.48 |
| 2022-06-30 | 14.80 |
| 2022-03-31 | 15.76 |
| 2021-12-31 | 13.11 |
| 2021-09-30 | 34.53 |
| 2021-06-30 | 28.27 |
| 2021-03-31 | 16.18 |
| 2020-12-31 | 1.22 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
